Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids.
about
Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment.A novel Alzheimer's disease drug candidate targeting inflammation and fatty acid metabolism.Endocannabinoid system in neurodegenerative disorders.Discriminative Properties of Hippocampal Hypoperfusion in Marijuana Users Compared to Healthy Controls: Implications for Marijuana Administration in Alzheimer's Dementia.
P2860
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids.
@ast
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids.
@en
type
label
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids.
@ast
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids.
@en
prefLabel
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids.
@ast
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids.
@en
P2093
P2860
P356
P1476
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids
@en
P2093
Aaron M Armando
Daniel Daugherty
David Schubert
Oswald Quehenberger
P2860
P2888
P356
10.1038/NPJAMD.2016.12
P577
2016-06-23T00:00:00Z
P6179
1002747791